Skip to main content
. 2012 Oct 8;6:1633–1638. doi: 10.2147/OPTH.S37252

Figure 2.

Figure 2

Mean change in central retinal thickness through 24 months for eyes with polypoidal choroidal vasculopathy treated with combined photodynamic therapy and intravitreal ranibizumab injection.

Notes: Vertical lines are 1 standard error of the mean. Central retinal thickness was significantly decreased from baseline through 24 months (*P < 0.05, Wilcoxon signed-rank test).